Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO13291 | Changium smyrnioides | Species | Apiaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 14581 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 13115.4 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 10417.9 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 92 | nM | PubChem BioAssay data set | |
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | 56.2 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Ki | = | 432000 | nM | 556774 |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Ki | = | 565000 | nM | 556774 |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Ki | = | 392000 | nM | 556774 |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Ki | = | 333000 | nM | 556774 |
NPT2 | Others | Unspecified | Kd | = | 0.122 | nM | 10.1039/C6MD00022C | |
NPT2 | Others | Unspecified | Kd | = | 33.9 | nM | 10.1039/C6MD00022C |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC125076 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC125076 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD807 | Approved |
1.0 | High Similarity | NPD808 | Approved |
0.7372 | Intermediate Similarity | NPD6121 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD3966 | Clinical (unspecified phase) |
0.6471 | Remote Similarity | NPD9402 | Discontinued |
0.6433 | Remote Similarity | NPD3876 | Approved |
0.6374 | Remote Similarity | NPD3877 | Approved |
0.6107 | Remote Similarity | NPD9104 | Approved |
0.5977 | Remote Similarity | NPD3333 | Approved |
0.5977 | Remote Similarity | NPD3332 | Approved |
0.596 | Remote Similarity | NPD1354 | Approved |
0.596 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.596 | Remote Similarity | NPD1356 | Approved |
0.5924 | Remote Similarity | NPD954 | Phase 1 |
0.5766 | Remote Similarity | NPD2663 | Approved |
0.5737 | Remote Similarity | NPD3469 | Phase 3 |
0.5714 | Remote Similarity | NPD6270 | Approved |
0.5699 | Remote Similarity | NPD3474 | Discovery |
0.5686 | Remote Similarity | NPD515 | Phase 1 |
0.5632 | Remote Similarity | NPD1122 | Clinical (unspecified phase) |
PubChem CID   | 23423984;6042 |
ChEMBL   | CHEMBL1588 |
ZINC   |
Molecular Weight:   | 265.11 |
ALogP:   | -2.3748 |
MLogP:   | 2.12 |
XLogP:   | 0.641 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 100.59 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 18 |